Skip to main content
Clinical Trials/NCT04427735
NCT04427735
Unknown
Not Applicable

Effect of Covid-19 Epidemic on Primary PCI and Prognosis in Patients With Acute STEMI

Beijing Friendship Hospital1 site in 1 country200 target enrollmentJanuary 24, 2019
ConditionsSTEMI

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
STEMI
Sponsor
Beijing Friendship Hospital
Enrollment
200
Locations
1
Primary Endpoint
all-cause death
Last Updated
5 years ago

Overview

Brief Summary

The epidemic of covid-19 has spread all over the world and has a great impact on people's health and life. It is necessary to study the treatment of STEMI patients in the real world under the influence of the epidemic,which provide effective suggestions and strategies for emergency and severe treatment.

Detailed Description

The epidemic of covid-19 has spread all over the world and has a great impact on people's health and life. The patients' prognosis is poor because the epidemic situation runs on medical resources, delays the diagnosis and treatment of other diseases such as cardiovascular diseases, and the patients' willingness to see a doctor is reduced. In particular, the delay in the treatment of STEMI, which needs PCI treatment, will cause more damage to the patients. It is necessary to study the treatment of STEMI patients in the real world under the influence of the epidemic. In this study, STEMI patients who experienced emergency PCI treatment after the covid-19 outbreak in 2020 were included, and compared with the data of the same period in 2019,we will analyze the pre hospital treatment time, vascular opening time,and the major cardiovascular adverse events, which provide effective suggestions and strategies for emergency and severe treatment.

Registry
clinicaltrials.gov
Start Date
January 24, 2019
End Date
July 24, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hongwei Li, MD

professor

Beijing Friendship Hospital

Eligibility Criteria

Inclusion Criteria

  • Continuous inclusion of patients with definite diagnosis of acute ST segment elevation myocardial infarction and emergency PCI intervention.

Exclusion Criteria

  • Febrile patients, patients with severe infection,
  • ST segment elevation myocardial infarction during hospitalization,
  • Patients who could not cooperate with each other.

Outcomes

Primary Outcomes

all-cause death

Time Frame: 1 year

death caused by all reason

MACE (major adverse cardiovascular events)

Time Frame: 1 year

cardiovascular death, re-infarction, malignant arrhythmia,heart failure, revascularization, and stroke

Study Sites (1)

Loading locations...

Similar Trials